Singapore Paincare Holdings (SGX:FRQ) Inventories, Raw Materials & Components: S$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Paincare Holdings Inventories, Raw Materials & Components?

Singapore Paincare Holdings SGX:FRQ Inventories, Raw Materials & Components is S$0.00 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Singapore Paincare Holdings's inventories, raw materials & components for the quarter that ended in Dec. 2025 was S$0.00 Mil.

Singapore Paincare Holdings's quarterly raw materials increased from Dec. 2024 (S$0.00 Mil) to Jun. 2025 (S$1.95 Mil) but then declined from Jun. 2025 (S$1.95 Mil) to Dec. 2025 (S$0.00 Mil).

Singapore Paincare Holdings's annual raw materials increased from Jun. 2023 (S$1.28 Mil) to Jun. 2024 (S$1.56 Mil) and increased from Jun. 2024 (S$1.56 Mil) to Jun. 2025 (S$1.95 Mil).

Singapore Paincare Holdings Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Singapore Paincare Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Paincare Holdings Inventories, Raw Materials & Components Chart

Singapore Paincare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only 0.77 0.00 1.28 1.56 1.95

Singapore Paincare Holdings Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.56 0.00 1.95 0.00

Singapore Paincare Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of S$0.00 Mil mean?
Singapore Paincare Holdings (SGX:FRQ) has a Inventories, Raw Materials & Components of S$0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Singapore Paincare Holdings and its competitors.
Is Singapore Paincare Holdings' Inventories, Raw Materials & Components too high?
Singapore Paincare Holdings' current Inventories, Raw Materials & Components is S$0.00 Mil.
How does Singapore Paincare Holdings' Inventories, Raw Materials & Components compare to HCA and THC?
Singapore Paincare Holdings' Inventories, Raw Materials & Components of S$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Healthcare Providers & Services company?
A good Inventories, Raw Materials & Components depends on the Healthcare Providers & Services industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Singapore Paincare Holdings and its competitors. Singapore Paincare Holdings's current Inventories, Raw Materials & Components is S$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Paincare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Singapore Paincare Holdings (SGX:FRQ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.17, compared to a current price of S$0.06 — trading 63.5% below its estimated fair value. The current Inventories, Raw Materials & Components is S$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Singapore Paincare Holdings (SGX:FRQ), the current Inventories, Raw Materials & Components is S$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Paincare Holdings Business Description

Address 601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, primary care, and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company operates mainly in Singapore.